AR-226-3578 - Definitive Study: Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry
EPA-HQ-OPPT-2020-0490-3390Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- AR-226-3578 - Definitive Study: Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry
- Posted
- Jul 22, 2026
- Topics
- Animal Health & Welfare
- Biomedical Research
- Chemical & Toxic Substances
- Food Safety & Nutrition
- Household Chemical Safety
- Manufacturing & Supply Chains
- Pharmaceutical Policy
- Product Safety & Recalls
- Public Health Infrastructure & Data
- Tax Policy & Reform
- Water Quality & Infrastructure
- Endangered Species & Wildlife
- Workplace Safety & OSHA